Malignant transformation of metachronous bilateral Schneiderian inverted papilloma of the lacrimal sac: management considerations and the contentious issue of orbital exenteration

[1]  P. Roche,et al.  Orbital exenteration in periorbital malignancies. , 2012, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[2]  R. Eisenberg,et al.  Surgical management of transitional cell carcinoma of the lacrimal sac: Is it time for a new treatment algorithm? , 2012, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[3]  S. Brar,et al.  Diagnosis and Management of Mucoepidermoid Carcinoma of the Lacrimal Duct , 2011, Orbit.

[4]  Marie Louise Roed Rasmussen,et al.  The Eye Amputated – Consequences of Eye Amputation with Emphasis on Clinical Aspects, Phantom Eye Syndrome and Quality of Life , 2010, Acta ophthalmologica.

[5]  T. Mom,et al.  Malignant lacrimal sac tumors. , 2010, European annals of otorhinolaryngology, head and neck diseases.

[6]  H. Soysal.  Orbital Exenteration: A 10-Year Experience of a General Oncology Hospital , 2010, Orbit.

[7]  A. McNab,et al.  Orbital Spread of Eyelid and Periocular Cutaneous Cancer , 2009, International ophthalmology clinics.

[8]  V. Lund,et al.  Management of the orbit in malignant sinonasal tumors , 2008, Head & neck.

[9]  P. Bradley,et al.  Risks of malignancy in inverted papilloma of the nose and paranasal sinuses , 2007, Current opinion in otolaryngology & head and neck surgery.

[10]  B. Leatherbarrow,et al.  Orbital exenteration: a 13 year Manchester experience , 2005, British Journal of Ophthalmology.

[11]  L. Barnes.  Schneiderian Papillomas and Nonsalivary Glandular Neoplasms of the Head and Neck , 2002, Modern Pathology.

[12]  J. Krouse.  Development of a Staging System for Inverted Papilloma , 2000, The Laryngoscope.